RAPP - Rapport Therapeutics Inc.
30.54
0.300 0.982%
Share volume: 887,968
Last Updated: 03-09-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.20%
PREVIOUS CLOSE
CHG
CHG%
$30.24
0.30
0.01%
View ratios
| Fiscal Date | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 08-08-2024 | 11-07-2024 | 03-11-2025 | 05-08-2025 | 11-06-2025 | |
| Cash flow financing | 0.000 | -1.394 M | 7.000 K | 5.000 K | 270.533 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 6.000 K | 270.470 M | |
| Cash flow | 0.000 | -70.850 M | 17.491 M | 799.000 K | 196.292 M | |
| Net income | -18.121 M | -17.537 M | 0.000 | -24.063 M | -26.925 M | |
| Depreciation | 0.000 | 219.000 K | 260.000 K | 244.000 K | 256.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | -53.041 M | 31.930 M | 21.031 M | -56.776 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 140.000 K | 0.000 | 291.000 K | 134.000 K | |
| Cash Change | 0.000 | -70.850 M | 17.491 M | 799.000 K | 196.292 M |